Market Place
Sourcing Support
MediciNova: Two Poster Presentations On MN-001 For Cardiometabolic At EAS
28 May 2024 //
GLOBENEWSWIRE
X4 Pharmaceuticals Announces Proposed Public Offering
06 Dec 2022 //
GLOBENEWSWIRE
MediciNova Receives a Notice of Allowance for a New Patent MN-001 and MN-002
13 Sep 2022 //
GLOBENEWSWIRE
MediciNova`s MN-001 Abstract Improves Serum Lipid Panel in T2D and NAFLD
09 Aug 2022 //
GLOBENEWSWIRE
MediciNova Announces Initiation of a PII Trial of MN-001 in NAFLD
26 Jul 2022 //
GLOBENEWSWIRE
MediciNova Announces MN-001 Research Collaboration with The Juntendo University
22 Jun 2022 //
GLOBENEWSWIRE
MediciNova Receives a New Patent Covering MN-001 for Cardi0-Metabolic Diseases
01 Feb 2022 //
GLOBENEWSWIRE
MediciNova Receives NOI to Grant New Patent Covering MN-001 and MN-002
26 Jan 2022 //
GLOBENEWSWIRE
MediciNova Announces MN-001 Data to be Presented at AASLD 2021
11 Nov 2021 //
GLOBENEWSWIRE
MediciNova Announces Presentation of Positive Findings on MN-001
12 Nov 2020 //
GLOBENEWSWIRE
MediciNova Receives Notice of Allowance for New Patent MN-001 and MN-002
18 Feb 2020 //
GLOBENEWSWIRE
MediciNova Receives Notice of Intention to Grant for New Patent Covering MN-001
28 Jan 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.